Balaxi Pharmaceuticals Ltd.

NSE: BALAXI

Balaxi Pharma Live Share Price Today, Share Analysis and Chart

Mid-range Performer

Iran war impact

Based on the latest financial disclosures and annual reports for 2025-26, the impact of the Middle East conflict on Balaxi Pharmaceuticals Ltd. (BALAXI) is characterized as minimal to neutral in terms of direct operational exposure, though it...

23.79 0.83 (3.61%)

65.75% Fall from 52W High

96,730

NSE Volume

NSE 10 Apr, 2026 3:31 PM (IST)

Loading... You have run out of DVM views!

Subscribe now to see details

Medium Financial Strength

- / 100

Mid Valuation

- / 100

Technically Neutral

43.4 / 100

Mid-range Performer These stocks have average quality, financial and technical momentum, indicating a mid range performer View Similar Embed DVM

No estimates available

Balaxi Pharma Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Is Balaxi Ventures Ltd. worth buying?

68 Votes:

Buy 69.12%

Sell 17.65%

Hold 13.24%